About Artemisshield
Advancing Animal Health with Science and Technology

Established on April 1, 2022, ArtemisShield Animal Health Co., Ltd. (ArtemisShield ) is a biotech company,  focusing on the research and development (R&D) of vector vaccines. The company has created a platform for vector vaccines and has developed reverse genetics operating systems for a wide range of viral vectors, including but not limited to Coronaviruses, Adenoviruses, Herpes viruses, and Parainfluenza viruses.

The company possesses an exceptional team of scientific and technological talents from diverse fields such as molecular biology, cell biology, and veterinary medicine. With their expertise, the company carries out cutting-edge gene editing and reverse genetics operation techniques to develop multi-disease and polyvalent vaccines,These vaccines are both safe and highly effective.

ArtemisShield adheres to the core principle of extreme deep cultivation and human-oriented  innovation,to fulfill its mission of striving for excellence and health protection. It is committed to safeguarding animal health and becoming a world-leading enterprise in the innovative animal vaccine domain.

R&D Innovation
ArtemisShield's co-founders have leveraged their respective strengths to create an efficient vector vaccine development platform.
The platform utilizes its cutting-edge gene editing technology and virus strains with exclusive intellectual property rights to develop genetically engineered viral vector vaccines. The goal is to develop multi-disease and polyvalent new marker vaccines capable of preventing multiple diseases. By doing so, the company can contribute to streamlining immunization programs and managing and controlling diseases.
  • R&D Team

    Notably, 30% of team members hold doctorate degrees, 71% possess a master's degree or higher, and all team members have at least an undergraduate degree.

  • R&D Laboratory

    The company's R&D laboratory covers an area of 1,650 square meters and is equipped with advanced experimental technologies and a well-designed laboratory environment.

  • Invention Patents

    Three invention patents

Products and Services
Dealing with the problems on animal health and making sure animals stay healthy

We utilize our cutting-edge gene editing technology to develop vector vaccines and swiftly form product categories that possess strong international market competency. The company has developed multi-disease and polyvalent vaccines for a variety of diseases, such as Coronaviruses, Adenoviruses, Herpes viruses, and Parainfluenza viruses.